Boston Sci's shares rise on analyst optimism; St. Jude gets FDA nod for remote monitoring network;

 @FierceMedDev: Quest takes $89.5M hit as it plots sale of Dx products unit. Report | Follow @FierceMedDev

@MarkHFierce: SV Bio says it is trying simplify gene sequencing for every day Dx purposes. System should be ready for market soon. Report | Follow @MarkHFierce

 @DamianFierce: And, finally, $COV has a renal denervation device on the market overseas. Story | Follow @DamianFierce

> Boston Scientific ($BSX) got its first major vote of confidence in a while: A Credit Suisse analyst upped his rating of the company, predicting 2014 revenue growth, and shares rose as much as 4% on Thursday. Story

> St. Jude Medical ($STJ) won FDA approval for its Merlin.net Patient Care Network, an Internet-based remote care system for patients with implanted medical devices. News

> Medtronic ($MDT) got FDA clearance for the FlexCath Advance Steerable Sheath to be used with the company's Arctic Front Advance Cryoballoon System, a treatment for paroxysmal atrial fibrillation. More

> Astellas Pharma and Roche Diagnostics ($RHHBY) have submitted the former's lung cancer drug Tarceva to the FDA, alongside a companion diagnostic designed by Roche. Release

> New research suggests that the use of advanced airway devices may not help EMTs resuscitate patients experiencing cardiac arrest. Article

> Argon Medical Devices has launched Cleaner15, a device designed for safe and effective thrombus removal for patients with renal disease. Item

Biotech News

 @FierceBiotech: Takeda's R&D boss infuses 'urgency' into Japan's No. 1 drugmaker. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: Buzz: AstraZeneca reorganization inspires fresh rumors of Shire bid. Story | Follow @JohnCFierce

@RyanMFierce: Pharma fumbles in recruitment game as clinical trials miss goals. Article | Follow @RyanMFierce

> Big Pharma drives R&D push for new drugs to treat neglected diseases. Report

> Bristol-Myers begins pricey post-mortem cleanup following 094 disaster. Story

Pharma News

@FiercePharma: Pfizer settles bellwether Chantix case ahead of next week's trial date. Amount undisclosed. More | Follow @FiercePharma

 @AlisonBFierce: WHO says dengue is the world's fastest-spreading tropical disease. GSK's dengue vaccine flopped in trials last year. News | Follow @AlisonBFierce

> EU signs off on Lilly's Amyvid, its diagnostic test for Alzheimer's. Story

> AZ enlists U.K. minister to help boost Brilique use. More

Drug Delivery News

> Pfizer launches first U.S. once-daily liquid ADHD drug. Article

> Clearside plans to move microinjections into clinic. Report

> BioTime seeks EU support for stem cell delivery gel. Story

> Aussie nanopatch offers new way to vaccinate. Item

> Bayer's extended use IUD nets FDA go-ahead. News

Suggested Articles

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.